Assignment of tumor subtype by genomic testing and pathologic-based approximations: implications on patient’s management and therapy selection

By Romero A.   Prat A.   García-Sáenz J.   Prado N.   Pelayo A.   Furió V.   Román J.   Hoya M.   Díaz-Rubio E.   Perou C.   Cladés T.   Martín M.  

Clinical and Translational Oncology, Vol. 16, Iss. 4, 2014-04 ,pp. : 386-394

Springer Publishing Company

Access to resources Recommend Favorite

Apoptotic markers for primary brain tumor prognosis

By Konstantinidou A.   Korkolopoulou P.   Patsouris E.  

Journal of Neuro-Oncology, Vol. 72, Iss. 2, 2005-04 ,pp. : 151-156

Springer Publishing Company

Access to resources Recommend Favorite

Ethical issues in the use of tumor markers in clinical investigation of the management of bladder cancer

By McCullough L.B.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 1, 2002-01 ,pp. : 35-37

Elsevier

Access to resources Recommend Favorite

Management of primary breast cancer in the elderly patient

By Blamey R.W.  

European Journal of Cancer, Vol. 39, Iss. 3, 2003-02 ,pp. : 286-286

Elsevier

Access to resources Recommend Favorite

Association of the MTHFR C677T polymorphism with primary brain tumor risk

By Xu Chen   Yuan Lutao   Tian Hengli   Cao Heli   Chen Shiwen  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3457-3464

Springer Publishing Company

Access to resources Recommend Favorite